These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16918372)

  • 1. Molecular determinants of vascular calcification: a bench to bedside view.
    Dellegrottaglie S; Sanz J; Rajagopalan S
    Curr Mol Med; 2006 Aug; 6(5):515-24. PubMed ID: 16918372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin.
    Collin-Osdoby P
    Circ Res; 2004 Nov; 95(11):1046-57. PubMed ID: 15564564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct comparison of regulators of calcification between bone and vessels in humans.
    Schweighofer N; Aigelsreiter A; Trummer O; Graf-Rechberger M; Hacker N; Kniepeiss D; Wagner D; Stiegler P; Trummer C; Pieber T; Obermayer-Pietsch B; Müller H
    Bone; 2016 Jul; 88():31-38. PubMed ID: 27108945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular calcification in type-2 diabetes and cardiovascular disease: Integrative roles for OPG, RANKL and TRAIL.
    Harper E; Forde H; Davenport C; Rochfort KD; Smith D; Cummins PM
    Vascul Pharmacol; 2016 Jul; 82():30-40. PubMed ID: 26924459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis.
    Schoppet M; Al-Fakhri N; Franke FE; Katz N; Barth PJ; Maisch B; Preissner KT; Hofbauer LC
    J Clin Endocrinol Metab; 2004 Aug; 89(8):4104-12. PubMed ID: 15292354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular calcification: lessons from scientific models.
    Sinha S; Eddington H; Kalra PA
    J Ren Care; 2009 Mar; 35 Suppl 1():51-6. PubMed ID: 19222732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular calcification in chronic kidney disease: a changing scenario.
    Cozzolino M; Brenna I; Ciceri P; Volpi E; Cusi D; Brancaccio D
    J Nephrol; 2011; 24 Suppl 18():S3-10. PubMed ID: 21623576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteogenic regulation of vascular calcification: an early perspective.
    Vattikuti R; Towler DA
    Am J Physiol Endocrinol Metab; 2004 May; 286(5):E686-96. PubMed ID: 15102615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of osteoprotegerin and its ligands and competing receptors in atherosclerotic calcification.
    Tintut Y; Demer L
    J Investig Med; 2006 Nov; 54(7):395-401. PubMed ID: 17169261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of OPG/RANKL/RANK axis on the vasculature.
    Papadopouli AE; Klonaris CN; Theocharis SE
    Histol Histopathol; 2008 Apr; 23(4):497-506. PubMed ID: 18228207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification.
    Kaden JJ; Bickelhaupt S; Grobholz R; Haase KK; Sarikoç A; Kiliç R; Brueckmann M; Lang S; Zahn I; Vahl C; Hagl S; Dempfle CE; Borggrefe M
    J Mol Cell Cardiol; 2004 Jan; 36(1):57-66. PubMed ID: 14734048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular calcification in patients with renal failure: culprit or innocent bystander?
    Dellegrottaglie S; Saran R; Rajagopalan S
    Cardiol Clin; 2005 Aug; 23(3):373-84. PubMed ID: 16084285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of OPG/RANKL in the pathogenesis of diabetic cardiovascular disease.
    Forde H; Davenport C; Harper E; Cummins P; Smith D
    Cardiovasc Endocrinol Metab; 2018 Jun; 7(2):28-33. PubMed ID: 31646276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular calcification in chronic kidney disease.
    Jono S; Shioi A; Ikari Y; Nishizawa Y
    J Bone Miner Metab; 2006; 24(2):176-81. PubMed ID: 16502129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of osteoclasts and osteoprotegerin on the mode of calcific degeneration of aortic valves.
    Lis GJ; Czubek U; Jasek-Gajda E; Łoboda A; Dulak J; Nessler J; Kapelak B; Sadowski J; Litwin JA
    Pol Arch Med Wewn; 2016; 126(3):149-58. PubMed ID: 27003233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Origin of the mediacalcosis in kidney failure].
    Torres PA
    J Mal Vasc; 2009 May; 34(3):204-10. PubMed ID: 19345526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vascular calcification: mutual interaction between bone and blood vessel].
    Yamaguchi A; Akashi T
    Clin Calcium; 2010 Nov; 20(11):1669-76. PubMed ID: 21037387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting local vascular and systemic consequences of inflammation on vascular and cardiac valve calcification.
    Hénaut L; Sanchez-Nino MD; Aldamiz-Echevarría Castillo G; Sanz AB; Ortiz A
    Expert Opin Ther Targets; 2016; 20(1):89-105. PubMed ID: 26788590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.
    Kon T; Cho TJ; Aizawa T; Yamazaki M; Nooh N; Graves D; Gerstenfeld LC; Einhorn TA
    J Bone Miner Res; 2001 Jun; 16(6):1004-14. PubMed ID: 11393777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification.
    Osako MK; Nakagami H; Koibuchi N; Shimizu H; Nakagami F; Koriyama H; Shimamura M; Miyake T; Rakugi H; Morishita R
    Circ Res; 2010 Aug; 107(4):466-75. PubMed ID: 20595654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.